Vertex Pharmaceuticals (VRTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX)

VRTX 470.53

+1.0%

Feb 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Spekulatius who wrote (584)	4/25/2002 2:00:27 AM
From: scaram(o)uche	Read Replies (1) of 1169

I believe that the Amgen trial was very large, and achieved only modest results on the "Enbrel" scale. I therefore wasn't expecting much, and this sounds OK to me. A 20% haircut? Yes, I realize that an ICE inhibitor is not equivalent to an IL-1 receptor antagonist. Again..... I have no interest, apart from my interest. :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next